SAT-458-YI Beneficial impact of consequent non-selective beta-blocker intake on patient outcomes in all stages of chronic liver disease
Josune Cabello Calleja, Jonel Trebicka, Manimozhiyan Arumugam(University of Copenhagen), Céline Chollet(Centre National de la Recherche Scientifique), Florence Castelli, Michael Praktiknjo, Michael Kuhn, Maria Papp, Minneke Coenraad, Christophe Junot, Sabine Klein, Wenyi Gu, Dávid Tornai(Beth Israel Deaconess Medical Center), Aleksander Krag, Robert Schierwagen(University of Münster)
Cited by 0
Related Papers
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
|Nature Biotechnology|2019|24.7k
Enterotypes of the human gut microbiome
|Nature|2011|7.6k
Richness of human gut microbiome correlates with metabolic markers
|Nature|2013|4.7k